Comments on: 6 Jun 2019 FDA AMDAC: Discussion of Pretomanid’s NDA for MDR-XDR TB

Comments on: 6 Jun 2019 FDA AMDAC: Discussion of Pretomanid’s NDA for MDR-XDR TB https://i-00ad6e92fcac1838b.amr.solutions/2019/04/24/6-jun-2019-fda-amdac-discussion-of-pretomanids-nda-for-mdr-xdr-tb/ Antimicrobial Resistance Solutions with Dr. John H. Rex Mon, 22 Jul 2024 15:29:37 +0000 hourly 1